Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
ALPCO Expands Product Offering with Addition of Flow Cytometry Reagents
After over twenty years of providing immunoassay kits worldwide, ALPCO has added flow cyometry reagents to their product offering. - March 25, 2013 - ALPCO
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine
Successful Pre-Clinical Tests Support Vaccine Platform, New Injection Protocol - March 19, 2013 - Arbovax Inc
Increasing Globalization Trends Driving the Market for Clinical Trial Cold Chain Services
A new report expects the total cold chain logistics spending on clinical trial materials to grow at a CAGR of around 4% during 2012-2016. - March 17, 2013 - IMARC Group
Dr. R. Wade McKenna to Speak on Stem Cell Therapy at T-POC & Newclip Technics 2013 Event
Dr. R. Wade McKenna, will share his expertise in stem cell therapy during the 2013 Dinner Event for The Progressive Orthopedic Company (T-POC) and Newclip Technics USA. The event will be held Friday, March 22 in Chicago, Illinois during the American Academy of Orthopaedic Surgeons 2013 Annual Meeting. - March 14, 2013 - Biologic Therapies
Polaris Study Offers Evidence of How Outcomes Management Technology Can Transform Child Welfare Services
Polaris shares the results of a multi-year study on the use of outcomes management technology in child welfare, and advocates for its widespread implementation. - March 14, 2013 - Polaris Health Directions
Healthcare Contract Research Outsourcing Market Research Report by Transparency Market Research
Transparency Market Research Add New “Healthcare Contract Research Outsourcing Market (Contract Research Organizations, Clinical Data Management, Clinical Trial Laboratories, Regulatory Medical Writing, Academic Medical Center) - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018” Market Research Report to It’s Database. - March 10, 2013 - Transparency Market Research
GenWay Biotech Names Dr. Ruben Flores-Saaib Vice President of Custom and Catalog Services
GenWay Biotech announces Ruben Flores-Saaib, PhD as Vice President of Custom and Catalog Services assuming responsibilities for the Company's custom services and catalog business operating activities. - March 06, 2013 - GenWay Biotech
ICRC-Weyer Take Leading Role in Pharmacovigilance Writing for Drug Safety Reporting
The German clinical contract research organization (CRO), ICRC-Weyer GmbH, is extending their Medical Writing Services with specialized Pharmacovigilance Writing, a comprehensive solution for regulatory-compliant drug safety reporting. - March 01, 2013 - ICRC-Weyer GmbH
Cliantha Research Partners with Acceliant for Its Clinical Trials
Acceliant, a global technology provider of innovative clinical trial data management solutions, today announced that Cliantha Research, a leading global Contract Research Organization, has chosen Acceliant's eClinical Suite for their clinical trial data management needs. Acceliant's integrated... - March 01, 2013 - Trianz
We-Care.com and AIDS Research Alliance Partner for HIV Research
AIDS Research Alliance (ARA) is pleased to announce that with We-Care.com’s generous support, it will be able to conduct the eight leukapheresis experiments necessary for the advancement of its promising HIV cure research. ARA was featured as We-Care.com’s Cause of the Month in December... - February 28, 2013 - AIDS Research Alliance
GHMI Partners with AnalizaDx to Bring Advanced Cancer Diagnostics to Africa
Simple blood-based cancer diagnostics and screening tests to enable early and effective treatment while reducing unnecessary procedures - February 27, 2013 - GHMI
Sengenics to Launch Global Biomarker Discovery and Clinical Trials Service Based on Oxford Gene Technology’s Patented Functional Protein Array
Sengenics today announced that it has signed an agreement with Oxford Gene Technology (OGT) to enable the launch of a global cancer biomarker discovery and clinical trial immuno-response monitoring service. The service will be based upon OGT’s proprietary full-length functional protein array... - February 25, 2013 - Sengenics
New Research Report on Cellular Therapy and Cord Blood 2013 Market Report by IndustryMonitor.co
IndustryMonitor.co Published Cellular Therapy and Cord Blood 2013 Market Report - February 25, 2013 - Industry Monitor
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report by IndustryMonitor.co
IndustryMonitor.co Published Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report. - February 25, 2013 - Industry Monitor
New Research Report MicroRNAs and Exosomes Market Report 2012 by IndustryMonitor.co
IndustryMonitor.co Published MicroRNAs and Exosomes Market Report 2012. - February 25, 2013 - Industry Monitor
New Osteoporosis Statistics Released by TestDiagnostics
TestDiagnostics market survey, found that the number of women and men being diagnosed with osteoporosis are rising at an alarming level. - February 16, 2013 - Test Diagnostics
IonSense to Present Direct Analysis in Real Time (DART®) Analysis for Rapid Drug Screening at the American Academy of Forensic Sciences (AAFS) 65th Annual Meeting
IonSense will present its DART-MS technology for rapid screening of urine samples using solid phase microfiber probes, enabling sample inspection for drugs of abuse in minutes. This is the first time IonSense will exhibit at the AAFS meeting, February 18-23, 2013 in Washington, D.C., Booth 405. - February 14, 2013 - IonSense, Inc.
iMPak Health Announces Agreement to License HealthSaaS Connected Outcomes Platform
iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak’s device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers. - February 13, 2013 - HealthSaaS, Inc
MarketResearchReports.biz Publishes Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
New Market Research Report Added in MarketResearchReports.Biz Database Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013 - February 13, 2013 - Market Research Reports.biz
Fruit Tree Nursery Offers Donations for Research During Congenital Heart Defect Awareness Week
Fruit tree nursery announces donation of gross sales to congenital heart defect research during Congenital Heart Defect Awareness Week, Feb. 7-14, 2012. - February 07, 2013 - Mac The Fire Truck
Bettie M. Steinberg Has Recently Been Recognized by Strathmore’s Who’s Who Publication
Bettie M. Steinberg, of Manhasset, New York, has recently been recognized by Strathmore’s Who’s Who Registry for her outstanding contributions and achievements in field of Medical Research. About Bettie M. Steinberg Bettie M. Steinberg is Chief Scientific Officer at the Feinstein... - February 06, 2013 - Strathmore Who's Who
Join the Team Contributing DNA Toward a Cure for Tourette Syndrome at Rutgers University
Yale University’s Dr. Robert King will interview individuals and families interested in participating in the genetics sharing program, in conjunction with the New Jersey Center for Tourette Syndrome, on February 14, 15 and 16 at Rutgers. - February 01, 2013 - New Jersey Center for Tourette Syndrome
New Jersey Tourette Syndrome Families Invited to Take Part in Research Conference
Current TS treatments and genetics research will be discussed March 9 at Overlook Medical Center’s Atlantic Neuroscience Institute. - February 01, 2013 - New Jersey Center for Tourette Syndrome
Paid Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Age 18+ with Type 2 Diabetes
This trial is a 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with T2DM inadequately controlled on a maximum tolerated dose or maximum dose according to local label of GLP-1 receptor agonist and metformin. - January 29, 2013 - Achieve Clinical Research
MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities
MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising... - January 28, 2013 - MOgene, LC
IonSense Awarded Massachusetts Workforce Training Grant. Adds New Sales Management.
IonSense, Inc. announced that they are a recipient of one of the 87 Workforce Training Grants awarded by the state of Massachusetts. This grant will enable the company to provide training to a number of employees in the areas of software development and engineering. “We are growing our... - January 25, 2013 - IonSense, Inc.
Stevens Undergraduates Present Research on Reducing Back Pain
Lower back pain is the second most common cause of disability for adults in the United States. Faced with the rising number of individuals suffering from the condition, undergraduate students Emily Noonan and Hanna Sidoti at the Stevens Institute of Technology will be presenting their research on... - January 24, 2013 - Stevens Institute of Technology
TechNavio Announces the Publication of Its Research Report - Global Non-Small Cell Lung Cancer Drugs Market 2012-2016
TechNavio's analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 2.77 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Ophthalmic Drugs market has also been witnessing the trend of emergence of personalized medicines. However, the increasing use of complementary and alternative medicine could pose a challenge to the growth of this market. - January 24, 2013 - TechNavio
EEG Awareness Weeks – What EEG Can do for a Trial
The Siesta Group announces the "EEG Awareness Weeks" from Jan 7 to Mar 31, 2013. During this time The Siesta Group’s CEO Georg Dorffner and CSO Peter Anderer will hold free webinars on the topic "What EEG can do for a trial." A free feasibility analysis concerning efforts and costs of including EEG in an early or late phase trial to address CNS efficacy or safety of a drug will be offered to all participants. - January 19, 2013 - The Siesta Group Schlafanalyse GmbH
Thalassemia Gene Therapy Study Begins Treating Participants
The first U.S.-based clinical trial in gene therapy has begun treating trial participants. This important Phase 1 trial introduces a functional version of a beta-globin gene into patients' stem cells. - January 13, 2013 - Cooley's Anemia Foundation
Families of Spinal Muscular Atrophy Committed $2.5 Million to Funding SMA Research in 2012
Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program, which includes: Basic Research to reveal the best ways of making SMA drugs; Drug Discovery to make practical new drugs, and; Clinical Trial resources... - January 01, 2013 - Cure SMA
Families of Spinal Muscular Atrophy Awards $710,000 for Basic Research to Identify New and More Effective Approaches for SMA Therapies
Continued investment in basic research leads to greater understanding of the exact nature, causes, and consequences of SMA. This knowledge is key to ensuring that the most effective SMA treatments can be identified and developed as quickly as possible. - December 29, 2012 - Cure SMA
Families of Spinal Muscular Atrophy Grants New Research Funding of $140,000 to Dr. Didonato of Northwestern University
Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program. This new research funding will support a project at Northwestern University to better understand when and where SMN protein is needed in less severe... - December 28, 2012 - Cure SMA
New Research Report on Rheumatology Therapeutics Market Analysis Done by MarketResearchReports
New Market Research Report Added in MarketResearchReports.Biz Reports Database Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth - December 22, 2012 - Market Research Reports.biz
General Biologicals Corporation Signs ALPCO as a Distributor in North America
ALPCO will distribute Infectious Disease assays from GBC in North America. - December 18, 2012 - ALPCO
Does You or Someone in Your Family Have Tourette Syndrome? Join the Team Contributing DNA Toward a Cure.
Yale University’s Dr. Robert King will interview individuals and families interested in participating in the genetics sharing program January 24 and 25 at Rutgers University. - December 14, 2012 - New Jersey Center for Tourette Syndrome
ALPCO Diagnostics Recognized in Support of American Red Cross’ Hurricane Sandy Relief Efforts
ALPCO presented with plaque of recognition for their contribution to the American Red Cross' Hurricane Sandy Relief Fund. - December 12, 2012 - ALPCO
New Organization Plans to Use Independent Peer Review to Put Millions of Hours Back Into Research
Announcing the launch of Rubriq, an organization addressing redundancy in the peer review system for scientific publishing. This new independent peer review system uses a standardized instrument that can be used by any journal, and will provide journal recommendations to authors based on their reviews. Rubriq is recruiting reviewers in all fields, and is now accepting manuscripts in immunology, cancer biology and microbiology during this initial beta phase. - December 12, 2012 - Rubriq
The Big Reveal - GenTech Launches New Look
A new year often brings a new look, but GenTech Scientific, Inc. could not wait until New Year's to reveal its extreme website makeover, including a new logo. “The new logo has a familiar feel. It incorporates foundational design elements that preserve the company's history. Yet it also... - December 11, 2012 - GenTech Scientific, Inc.
ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agreement at MEDICA 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012 - ALPCO
ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreement
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012 - ALPCO
Erratum: Web of Stories Hosts New Videos of Microbiologist Leonard Hayflick, Who Produced the First Oral Polio Vaccine Made in a Continuously Propagated Cell Strain
Best known for his pioneering research on the ageing process, Leonard Hayflick is an internationally recognised microbiologist whose work has revolutionised cell biology. Web of Stories presents a comprehensive and insightful video archive of the man behind the "Hayflick limit." - December 01, 2012 - Web of Stories Ltd
Watch the Life Stories of Leonard Hayflick: Web of Stories Hosts Brand New Videos of the Microbiologist Who Produced the First Oral Polio Vaccine
Best known for his pioneering research on the aging process, Leonard Hayflick is an internationally recognised microbiologist whose work has revolutionised cell biology. Web of Stories presents a comprehensive and insightful video archive of the man behind the "Hayflick limit." - November 30, 2012 - Web of Stories Ltd
New Phase 3 Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Now Enrolling Participants Age 18-75
The primary objective of this study is to evaluate the 24-hour spirometric effect (FEV1) of a new drug over a 12-week treatment period in subjects with COPD. - November 15, 2012 - Avail Clinical Research
Sengenics Announces Exclusive Agreement with the Sequenom Center for Molecular Medicine to Provide Its Non-Invasive Prenatal Trisomy Test in Malaysia and Singapore
Sengenics, Asia’s 1st Genetic Diagnostics Company, today announced that it has entered into an exclusive agreement with The Sequenom Center for Molecular Medicine (Sequenom CMM), to launch and promote its MaterniT21 PLUS non-invasive prenatal testing service in Malaysia and... - November 13, 2012 - Sengenics
Sarasota Memorial Hospital Selected as Study Site for WARFARIN Personalized Medicine Trial
The first major personalized medicine study authorized by the Centers for Medicare & Medicaid Services, the FDA-approved study will assess the impact of genetic testing in reducing hospitalizations and deaths caused by the commonly prescribed blood thinner Warfarin. - November 04, 2012 - Sarasota Memorial Health Care System
Initiation of 2nd International Conference on Forensic Research and Technology
After the generous response and active participation from the investigators, scientists, researchers and leaders from field of Forensic Research and Technology in 2012, OMICS Group Inc. takes immense pleasure to announce 2nd International Conference on Forensic Research and Technology with the theme “Novel perspectives of forensics to safeguard Law & Justice.” - November 01, 2012 - OMICS Group Incorporation
Acceliant to Participate in DIA India's 7th Annual Conference to be Held at Hyderabad
Acceliant, a global technology provider of innovative clinical solutions, will participate in DIA India's 7th Annual Conference, scheduled for Nov. 1-4, 2012 at the Hyderabad International Convention Center, Novotel & HICC Complex, Hyderabad. Acceliant invites all the conference attendees to... - October 27, 2012 - Trianz
Rosellini Scientific, LLC Announces Recent Hire of Dr. Austin Duke as Vice President of Emerging Technologies
Rosellini Scientific, LLC is pleased to announce the recent hire of Dr. Austin Duke to join their team as Vice President of Emerging Technologies. - October 26, 2012 - Rosellini Scientific, LLC
The Essentials for Understanding How to Put Spinal Cord Injury Research Into Clinical Practice
According to the National Spinal Cord Injury Statistical Center, there are approximately 12,000 new cases of spinal cord injury per year in the United States alone. There have been some extraordinary breakthroughs in spinal cord injury (SCI) research recently, and the challenge is to ensure that... - October 26, 2012 - Thieme Publishers